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Hereditary retinal degenerations (HRDs) are Mendelian diseases characterized by pro-
gressive blindness and caused by ultra-rare mutations. In a genomic screen of 331 unrelated
Japanese patients, we identify a disruptive Alu insertion and a nonsense variant (p.Arg1933*)
in the ciliary gene RP1, neither of which are rare alleles in Japan. p.Arg1933* is almost
polymorphic (frequency= 0.6%, amongst 12,000 individuals), does not cause disease in
homozygosis or heterozygosis, and yet is significantly enriched in HRD patients (frequency=
2.1%, i.e., a 3.5-fold enrichment; p-value= 9.2 × 10−5). Familial co-segregation and associa-
tion analyses show that p.Arg1933* can act as a Mendelian mutation in trans with the Alu
insertion, but might also associate with disease in combination with two alleles in the EYS
gene in a non-Mendelian pattern of heredity. Our results suggest that rare conditions such as
HRDs can be paradoxically determined by relatively common variants, following a quasi-
Mendelian model linking monogenic and complex inheritance.
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Together with intellectual disabilities, hereditary retinaldegenerations (HRDs, comprising retinitis pigmentosa andallied diseases) represent a group of conditions for which
both genetic and allelic heterogeneity is the highest in humans1,2.
To date, almost 300 genes and thousands of mutations have been
identified as causative of HRD, and the detection of novel disease
genes and variants continues at a steady pace (RetNet database:
https://sph.uth.edu/retnet/). Considering that the overall pre-
valence of HRDs does not exceed 1 in 2000 individuals, the
average contribution of any given HRD gene to the disease is
incredibly small. Similarly, apart from two DNA variants that
appear to be relatively frequent in the general population
and determine a specific form of the disease (p.Asn1868Ile and
p.Gly863Ala in ABCA4)3,4, most mutations are so rare that they
are seldom detected in more than one pedigree, worldwide. In
addition, although HRDs affect people from the five continents,
their specific allelic assortment seems to be population-specific5,6.
For instance, similar to other islanders or groups of people that
have experienced relative historical isolation, Japanese carry cer-
tain alleles, including pathogenic ones, which are not found
elsewhere in the world7. Furthermore, lack of significant reduc-
tion in fitness before the reproductive age, associated with such an
elevated heterogeneity, have led to the consequence that the
number of recessive mutations that are detected heterozygously in
the general, unaffected population is remarkably high and may
affect up to one person in two8.
Despite this extraordinary variability and abundance of
mutations, HRDs are almost invariantly inherited as a mono-
genic, Mendelian trait, for which the presence of only one
(dominant) or two (recessive) mutations in the same gene, gen-
ome-wide, is at the same time a necessary and sufficient condition
for pathogenicity9. At the other end of the spectrum of ocular
conditions having a genetic component lies age-related macular
degeneration (AMD), another retinal disease affecting people
aged 50 and over. AMD is a bona fide complex disease with a
relatively high prevalence (1 in 13 individuals), favored by the
presence of polymorphic SNPs, highly penetrant rare variants,
and environmental factors10. Between these two pillars of
inheritance, there is an intermediate zone, consisting in a few
examples for which extremely rare mutations in more than one
gene are associated with Bardet–Biedl syndrome, a retinal cilio-
pathy displaying sometimes digenic triallelic inheritance11–13.
RP1 is one of the several HRD genes identified to date, and one
of the few causing disease by more than one Mendelian pattern of
inheritance. Originally described as linked to autosomal domi-
nant retinitis pigmentosa (adRP)14–16, a subtype of HRD, it was
later shown to be associated with a recessive form of the same
disease (arRP)17. To date, at least 60 mutations have been
reported in RP1, most of which cluster within its last exon (exon
4), cumulatively accounting approximately for 5.5% and up to
4.5% of all adRP and arRP cases, respectively18,19. However, some
DNA variants at the far 3’ end of the gene, including nonsense
variants, appear not to cause disease, at least not according to a
dominant or recessive pattern of inheritance20,21. RP1 encodes a
multi-modular protein of 2156 amino acids, which is a member of
the doublecortin family and is present in the ciliary axoneme of
both rods and cones, the light-sensing neurons of the retina22,23.
Mutations in RP1 thus determine visual loss as a consequence of a
ciliopathic phenotype affecting these specialized cell types.
Following the screen of a large set of Japanese HRD patients,
we identify three mutations in the RP1 gene: a mobile Alu ele-
ment insertion in exon 4, a novel frameshift mutation, and a
nonsense variant in the far 3’ part of the coding sequence. While
the first two variants behave as classical recessive Mendelian
alleles, NM_006269.1:c.5797C>T/p.Arg1933* appears to cause
disease according to a more complex pattern of inheritance.
When present in trans with respect to the Alu insertion, it acts as
a Mendelian mutation. Furthermore, despite being enriched in
patients vs. controls, p.Arg1933* is completely benign in homo-
zygosis or in heterozygosis. By performing an association test
between 28 HRD patients, heterozygous carriers of this nonsense
allele, and 3554 controls, we find that p.Arg1933* may be
pathogenic not only as a Mendelian allele, but also in association
with variants elsewhere in the genome, and in particular with two
DNA changes in another ciliary gene, EYS.
Results
An Alu insertion in RP1 is a prevalent cause of HRD in Japan.
In the framework of a screening effort of 331 unrelated Japanese
patients, we identified a novel, unusual mutation by whole-
genome sequencing, consisting in the insertion of a mobile Alu
element in exon 4 of the RP1 gene (m1, or NM_006269.1:
c.4052_4053ins328/p.Tyr1352Alafs*9) in a female individual
from a recessive HRD family. This insertion caused the disrup-
tion of the reading frame by introducing 328 additional nucleo-
tides, including a premature termination codon in the canonical
RP1 coding sequence. The mother of the proband was hetero-
zygous for this variant and the proband’s affected brother was
also a homozygote, in support of the notion that this was indeed a
recessive HRD mutation (Fig. 1a). Targeted screening for this Alu
insertion in the remaining 330 patients (all forms of HRDs, iso-
late or recessive cases, not genetically pre-screened), as well as in
524 Japanese controls, available for direct testing of m1, identified
15 other affected and unrelated individuals and one heterozygous
control carrying this insertion. In total, six patients were homo-
zygous for the mutation (12 alleles), which co-segregated with the
disease as a classical Mendelian, recessive allele, whenever this
could be tested, while 10 carried it heterozygously. Altogether,
these findings indicate that this Alu insertion is not only clearly
pathogenic, but it is also a rather prevalent cause of retinal
degeneration within the Japanese islands at the level of a single
allele (1.8% of all HRD Japanese patients), possibly second only to































Fig. 1 Segregation analysis of the RP1 mutations found in this study.
Pedigrees of representative families are shown
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Remarkably, 6 of the 10 individuals who carried the Alu
insertion heterozygously were in fact compound heterozygotes for
either of two other changes in RP1: a novel frameshift mutation
(c.4196del/p.Cys1399Leufs*5, m2, two unrelated individuals) and
a nonsense variant c.5797 C > T/p.Arg1933* (m3, four unrelated
individuals) that was previously identified in the general
population and is present in dbSNP as entry #rs118031911
(Supplementary Table 1). Again, both variants, detected by direct
Sanger sequencing, co-segregated with the disease in relevant
families, according to an autosomal recessive pattern of
inheritance (Fig. 1b–d).
m3 is enriched in patients, but does cause HRD per se. Fra-
meshift c.4196del/p.Cys1399Leufs*5 (m2) was absent from 3480
Japanese control chromosomes and was reported in the gnomAD
database27 to have an allele frequency of 5.44 × 10−5 in East Asia,
indicating that this DNA variant is a very rare allele, as it is the
case for most HRD mutations.
In contrast, the rs118031911/T allele (m3), despite being
virtually absent in many world populations, was found to be
relatively frequent in East Asians (Supplementary Fig. 1), and
probably too frequent to be a Mendelian allele for HRD,
according to the Hardy–Weinberg model. In particular, our
direct screening of 12,379 Japanese individuals with no retinal
degeneration showed the presence of rs118031911/T in
145 subjects, 142 heterozygotes and 3 homozygotes (148
alleles), validating the notion that this DNA variant is in fact
almost polymorphic in Japan (allele frequency= 0.6%). All
these subjects were examined by fundoscopy and, in addition,
we evaluated clinically one of the three homozygotes (the only
one who could be re-assessed, in agreement with our
Institutional Review Board protocol) by a very thorough
ophthalmological examination. At age 28 years old, she had
no visual symptoms and displayed no ocular abnormalities: she
had normal visual acuity (20/20 in both eyes), intact visual field
(Goldmann perimetry), and no evidence of retinal degeneration
through slit lamp examination and fundoscopy. Furthermore,
optical coherence tomography imaging, used to assess detailed
retinal structures, showed no signs of retinal thinning and
electroretinogram, a test allowing objective detection of
minimal retinal dysfunction even in the absence of subjective
symptoms, showed normal responses. Finally, absence of late-
onset HRD, who could have escaped detection in a 28-year-old
individual, was confirmed by the assessment of the fundi of the
other two rs118031911/T homozygotes, who displayed no signs
of retinal degeneration at ages of 78 and 79 years, respectively.
Overall, both population based-data and direct clinical assess-
ments confirm that rs118031911/T does not cause HRD per se,
in heterozygosis or in homozygosis.
However, specific screening for the rs118031911/T allele in
the same cohort of 331 Japanese HRD patients mentioned
above led to the identification of 10 additional heterozygotes
(14 alleles in total) showing that its frequency in HRD patients
was 2.1% (14 alleles out of 662) (Supplementary Fig. 1). The
3.5-fold enrichment of rs118031911/T in patients vs. controls
(148 alleles out of 24,758= 0.6%) was highly significant [p-
value= 9.2 × 10−5, threshold= 0.05/N, N= 1, by Fisher’s exact
test (24,610:148 vs. 648:14)], indicating that this relatively
common variant has in fact an effect on retinal health. WES
analysis of these 10 patients detected no mutations in HRD
genes that could explain their phenotype, according to a
Mendelian fashion of inheritance. Considering that
rs118031911/T introduces a nonsense codon in the RP1 open
reading frame and was found in trans with respect to the Alu
insertion in some patients, it is not unlikely that it could
represent a hypomorphic variant contributing to the mutational
load of genes involved in retinal homeostasis. In other words,
despite being benign when considered as a Mendelian allele
(monoallelically or biallelically), rs118031911/T could exert a
pathogenic function in conjunction with DNA changes in other
known HRD genes, according to an oligogenic pattern of
inheritance that was previously modeled for hereditary
ciliopathies28–30.
A non-Mendelian pattern of inheritance for m3. We tested this
hypothesis by assessing enrichment of nonsynonymous, rare, and
low-frequency variants (minor allele frequency between 0.1% and
5%, according to published literature; further details in Methods)
in m3 carriers. We analyzed the 10 patients mentioned above, as
well as 18 additional patients with the same genotype (hetero-
zygous for rs118031911/T, with no other recognized mutations in
RP1 and no mutations in HRD genes that could explain their
phenotype), identified following a targeted screening of 713
Japanese HRD cases from another internal cohort (Supplemen-
tary Table 1). Specifically, we performed an association test
between these 28 individuals and 3554 Japanese controls from the
3.5KJPN database31 by considering all 228 bona fide HRD
genes32 from the RetNet database (Supplementary Table 2) that
could produce multiallelic inheritance of HRD in m3 hetero-
zygotes, in line with previous protocols involving similar ana-
lyses33–38. Cryptic relatedness among patients, as well as the
presence of additional, undetected RP1 mutations in trans with
respect to rs118031911/T were excluded prior to performing
the test (Supplementary Table 3 and Supplementary Data 1).
The association analysis identified two variants that were sig-
nificantly enriched in patients vs. controls (Table 1, Fig. 2).
Interestingly, although they were not in linkage disequilibrium,
both variants belonged to the gene EYS (NM_001142800.1:c.2528
G > A;p.Gly843Glu and c.8805 C > A;p.Tyr2935*, p-values=
5.6 × 10−5 and 1.9 × 10−4, respectively; threshold= 2.8 × 10−4=
0.05/N, where N= 178, by Fisher’s exact test), possibly high-
lighting a mechanism of pathogenesis directly involving the
proteins EYS and RP1. Indeed, a third DNA change within EYS
(c.4957del;p.Ser1653Valfs*26) ranked 3rd in the list of associated
variants, even if its p-value did not reach statistical significance
after Bonferroni correction. Furthermore, we performed the same
analysis by considering not only variants from RetNet sequences,
but from the whole human exome, in both cohorts. In support of
the data obtained, the two significant hits detected in the HRD
gene set were also the two top hits detected exome-wide, even
though no variant reached the threshold for exome-wide sig-
nificance. Altogether, these results indicate that the rs118031911/
T nonsense could act in concert with at least two DNA changes
(and possibly with more) to determine a pathological phenotype
in a non-Mendelian fashion.
Based on previous data on Bardet-Biedl syndrome11, we
tested a digenic diallelic vs. triallelic mode of action for
rs118031911/T on HRD, by comparing the frequency of this
variant in patients for whom the molecular causes of retinal
degenerations were identified (i.e., solved cases) vs. unsolved
HRD cases vs. controls. As expected, a comparison of unsolved
vs. controls showed significance, as reported above, whereas
solved vs. controls did not show any significant enrichment for
rs118031911/T (6 rs118031911/T variants over 722 alleles for
solved vs. 148 over 24,758 for controls, p-value= 0.46, OR=
1.4, CI= 0.50–3.14, by Fisher’s exact test). Comparison of
solved vs. unsolved HRD cases showed borderline non-
significant enrichment for rs118031911/T in unsolved cases
(p-value= 0.07, OR= 2.30, CI= 0.94–6.76, by Fisher’s exact
test), possibly indicating that either well-defined triallelism does
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not take place for this variant or that we did not have enough
power to detect it.
Discussion
The extreme genetic heterogeneity of retinal degenerations,
together with the elevated number of pathogenic and hypo-
morphic changes in HRD genes that are detected in the unaf-
fected population, have evoked the theoretical possibility that
non-Mendelian, oligogenic inheritance could be responsible for
these conditions9. Digenic heredity has been clearly demonstrated
for specific combinations of mutations39–41 in particular pedi-
grees or in individual cases, including digenic triallelic trans-
mission of Bardet–Biedl syndrome11,42. For these patients, the
presence of two (diallelic) or three (triallelic) mutations at two
different loci (digenism) causes disease, presumably by compro-
mising the overall function of gene products that belong to the
same complex or are part of the same biochemical pathway. This
model seems to be particularly true for genes encoding for
proteins that form or play a role within the cell primary cilium,
according to the paradigm of mutational load put forward by N.
Katsanis and coworkers43. In these instances, accumulation of
rare variants (which individually may have a little effect) in
multiple ciliary genes can produce a pathological phenotype that
is connected to ciliary function and result in a ciliopathy,
including retinal ciliopathies44–46.
Intriguingly, despite our association test was not limited to ciliary
genes, both our significant hits lie within a ciliary gene, EYS. In
primates, the EYS protein has been shown to physically co-localize
with RP1 in the ciliary axoneme of photoreceptors and is thought to
play a role in the structural organization and maintenance of these
cells’ apical part, the outer segment (OS)47. This functional role is
further supported by studies in zebrafish, where EYS knockouts
show progressive retinal degeneration due to mis-localization of
specific OS proteins and the disruption of F-actin filaments48,49, a
key component not only for the integrity, but also for the mor-
phogenesis of the OS50. In a similar fashion, targeted disruption of
the RP1 gene in mice leads to defects of the OS, because of the
incorrect stacking of its discs51. The co-localization of RP1 and EYS,
as well as their common role in the homeostasis of the OS, strongly
indicates that they may have synergic functions and that patho-
genesis could occur in a digenic fashion.
In this work we show that two specific RP1 alleles are responsible
for a relatively large number of Mendelian HRD cases in Japan.
Interestingly, none of these two changes is a rare allele at all,
compared to the average frequencies of classical HRD mutations.
The first, the c.4052_4053ins328/p.Tyr1352Alafs*9 Alu element
insertion in RP1 (m1), seems to be the second most common HRD
recessive mutation described so far in Japan, and its frequency may
even be underestimated, since insertional events of mobile elements
are difficult to detect by conventional screening techniques. The
second variant, c.5797 C > T/p.Arg1933* or rs118031911/T (m3), is
even more frequent, and by far more interesting. Despite introdu-
cing a premature stop codon in the RP1 open reading frame, this
DNA change is almost polymorphic in East Asia and does not cause
disease either in heterozygous or homozygous carriers. However,
this same change may act as pathogenic allele in a Mendelian
fashion (with another RP1mutation in trans), or in association with
rare variants in at least another gene, according to a non-Mende-
lian, possibly oligogenic pattern of inheritance. Although we cur-
rently ignore the molecular mechanisms leading to this unusual
model of pathogenicity, it is probably the consequence of an
increased global mutational load with threshold effect, determined
by the accumulation of variants with different pathogenic potential.
The presence of one or of two rs118031911/T alleles likely produces
a load that is below this pathological threshold, while the co-
Table 1 Summary of the results of the association study
Gene Variant Frequency in cases Frequency in controls OR 95% CI (OR) p-value
EYS NM_001142800.1:c.2528G>A; p.Gly843Glu 0.125 0.017 8.23 3.08–18.78 5.6E-05*
EYS NM_001142800.1:c.8805C>A; p.Tyr2935* 0.054 0.002 33.30 5.86–128.76 1.9E-04*
EYS NM_001142800.1:c.4957del; p.Ser1653Valfs*26 0.054 0.004 13.85 2.62–46.83 1.9E-03
USH2A NM_206933.2:c.15355C>T; p.Arg5119Trp 0.036 0.002 20.15 2.16–92.44 5.9E-03
USH2A NM_206933.2:c.2802T>G; p.Cys934Trp 0.036 0.003 14.55 1.60–63.22 0.010
PDZD7 NM_024895.4:c.1267G>A; p.Ala423Thr 0.036 0.003 13.38 1.48–57.70 0.012
EYS NM_001142800.1:c.7394C>G; p.Thr2465Ser 0.089 0.029 3.28 1.01–8.30 0.024
CC2D2A NM_001080522.2:c.501G>T; p.Lys167Asn 0.036 0.004 8.44 0.96–34.65 0.027
RPGRIP1L NM_015272.4:c.171G>T; p.Leu57Phe 0.054 0.011 4.90 0.96–15.63 0.028
BBIP1 NM_001243783.2:c.112T>C; p.Ser38Pro 0.036 0.005 7.70 0.87–31.35 0.032
Note: The top 10 hits from this test are shown
OR odds ratio, CI confidence interval
*p-values retaining statistical significance























Fig. 2 Results of the association study. Quantile–quantile (Q–Q) plot of
rare/low-frequency non-synonymous variants in HRD genes in 28 patients
heterozygous for rs118031911/T vs. 3554 Japanese controls. The
significance threshold is indicated by the dotted line
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occurrence of extra variants could result in the crossing of such a
limit for normal retinal homeostasis. This hypothesis is supported
by the evidence that rs118031911/T is pathogenic in conjunction
with a very severe mutation, i.e., the insertion of an Alu element in
RP1’s exon 4 mentioned above, which completely ablates the open
reading frame of the gene. We term this model of inheritance quasi-
Mendelian, to define the differential behavior (Mendelian or non-
Mendelian) that specific alleles may have with respect to different
genotypes at the same locus or elsewhere in the genome.
In conclusion, it seems that, at least for RP1-associated HRD,
disorders displaying a Mendelian pattern of inheritance may also
genetically behave like multigenic conditions, for which both
polymorphic (having a low effect) and rare (having a rather high
effect) variants can determine pathogenesis (Fig. 3). The findings
from our study require further replication, ideally in other East
Asian cohorts. However, the low prevalence of HRD and the even
lower percentage of HRD patients carrying rs118031911/T limit
our ability to assemble cohorts of sufficient power at this time,
which would not only enable us to validate our findings but also
to propose more defined models of pathogenicity. To better
illustrate this: the identification of the 28 heterozygotes reported
in this study corresponds to the screening of roughly 5–10 million
Japanese individuals. Nevertheless, our work provides a proof of
concept that a non-negligible proportion of HRDs can be caused
by inheritance mechanisms that transcend the Mendelian model,
to be investigated in detail by future, very large-scale and
population-specific sequencing endeavors, such as for instance
the 100,000 genomes project52. Furthermore, our findings suggest
that oligogenic heredity of human diseases (and perhaps of other
traits) may not be limited to a low number of cases with ultra-rare
conditions, as shown up to now34,35,53,54, but could extend to
more frequent phenotypes and represent a bridge between
monogenic and complex inheritance.
Methods
Subjects. The study was initiated following the approval by the Institutional
Review Boards of our respective Institutions (University of Lausanne, Yokohama
City University Graduate School of Medicine, Radboud University Medical Center,
Kyushu University, Nagoya University Graduate School of Medicine, Tohoku
Medical Megabank Organization, Juntendo University School of Medicine, Tohoku
University Graduate School of Medicine, and Tokyo Medical and Dental Uni-
versity). All subjects provided written informed consent, and the study was con-
ducted in adherence with the Declaration of Helsinki.
Tohoku University School of Medicine, Kyushu University School of Medicine,
and Nagoya University School of Medicine, all based in Japan, were the centers
where all Japanese patients with HRD were recruited. HRD was diagnosed
clinically after excluding possible secondary causes of retinal degeneration such as
toxicity and uveitis. Final diagnosis required the presence of reduced
electroretinogram (ERG) responses, visual field loss, and funduscopic
abnormalities consistent with retinal degeneration (retinal vascular narrowing and
abnormalities of the retinal pigment epithelium etc.) symmetrically in both eyes.
Genotypes from individuals without HRD were collected from both published
and unpublished databases [the BioBank Japan Project (N= 12,379), the ToMMo
Japanese Reference Panel Project (3.5KJPN release, N= 3554)31, the Tohoku
University School of Medicine (N= 95), the Yokohama City University Graduate
School of Medicine (N= 429)] or were obtained experimentally by direct
genotyping of genomic DNA, with standard molecular biology techniques.
Summary phenotypes of carriers of m1, m2, or m3 mutations are listed in
Supplementary Table 1.
Whole genome sequencing and analysis. Genome sequencing of the first index
patient was performed using the sequencing platform by Complete Genomics55.
Sequence reads were mapped to the human reference genome (NCBI build 37) and
variants were called genome-wide. These included: single-nucleotide variants
(SNVs), copy-number variations (CNVs), as well as structural variations (SVs)
such as Alu element insertions and/or chromosomal rearrangements. Data were
extracted from MasterVar files and other relevant matrices by ad hoc Perl, bash,
and R scripts, available upon request. Assessment of pathogenic variants was
performed as previously described56.
Screening for the Alu element insertion. In order to screen for the presence of
the Alu element in exon 4 of RP1 distinct pair of primers were designed (forward:
5′-AGGCTTGTTTCCTAGGAGAGGT-3′, reverse: 5′-
TTCTGCTTCTTTTTCACTTAGGC-3′) using the CLCbio Genomics Workbench
(Qiagen, Hilden, Germany).
PCR amplification was performed in a 20 μl total volume containing 20 ng
genomic DNA, 1× GoTaq buffer, 0.5 mM dNTPs, 10 μM of each primer, and 2
units (5 U/μl) of GoTaq polymerase (Promega, Madison, Wisconsin). PCR
products were separated following agarose gel electrophoresis. PCR products
displaying abnormal size profiles were purified (ExoSAP-IT, USB, Cleveland Ohio)
and a sequencing reaction was performed in a total volume of 5 μl using 1 μl primer
3.3 µM, 0.5 μl BigDye Terminator v1.1, and 1 μl of the provided Buffer (Applied
Biosystems, Foster City, California) Big Dye terminator cycle sequencing kit on an
ABI 3130xl Genetic Analyzer (Applied Biosystems).
For this screening, we used 524 controls from the Tohoku University School of
Medicine (N= 95) and the Yokohama City University Graduate School of
Medicine (N= 429).
Whole exome sequencing and analysis. Paired-end DNA sequencing libraries of
28 individuals were generated using Aglilent SureSelect Human All ExonV6 kit
(Agilent Technologies, CA, USA) by Novogene Co., Ltd., Hong Kong. One
microgram of genomic DNA per sample was fragmented into 180–280 bp frag-
ments by hydrodynamic shearing (Covaris, Massachusetts, USA). After the
Mendelian







Fig. 3 Schematic representation of the inheritance pattern of the identified mutations in RP1, highlighting the concept of rs118031911/T-mediated quasi-
Mendelian inheritance of HRDs. a In trans with respect to the Alu element insertion (m1, or c.4052_4053ins328/p.Tyr1352Alafs*9), m3 (rs118031911/T, or
c.5797C>T/p.Arg1933*) results in autosomal recessive inheritance of the disease, similar to m1 in a homozygous state or in a compound heterozygous
combination with m2 (c.4196del/p.Cys1399Leufs*5). b Combinations of the hypomorphic m3 allele with additional hypomorphs and/or heterozygous
recessive alleles in other genes result in disease following a non-Mendelian pattern, whereas (c) homozygosis for m3 has no pathological consequences.
d Structure of RP1: exons are represented by boxes, connected by solid lines (introns). The relative positions of m1, m2, and m3 are also indicated
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reparation of the 3’ and 5’ ends and the adenylation of the 3’ ends, paired-end
adaptors were ligated to the DNA fragments. DNA fragments with ligated adaptors
on both ends were enriched by PCR. PCR products were further purified using the
AMPure XP system (Beckman Coulter, Beverly, USA) and quantified using the
Agilent high sensitivity DNA assay on the Agilent Bioanalyzer 2100 system.
Captured DNA fragments were sequenced on an Illumina NovaSeq 6000 platform
(Illumina, San Diego, California).
Raw sequence files were assessed, trimmed, and mapped to the human genome
reference sequence (UCSC hg19) using Novoalign V3.08.02 (Novocraft, Selangor,
Malaysia). Variants were called jointly by GATK 3.857 and annotation was
performed using EPACTS (http://genome.sph.umich.edu/wiki/EPACTS) and
Annovar58. The nomenclature of all variants studied was validated by using
VariantValidator59.
All single nucleotide variants were further filtered to obtain only high-quality
variants. Briefly, quality control was carried out using the following parameters: (1)
remove individual calls if Depth (DP) < 8 or GenotypeQuality (GQ) < 20, (2)
exclude variants if the average GQ value ≤35, (3) exclude variants if call-rate
value ≤ 0.9, (4) keep only variants with no deviation from Hardy-Weinberg
equilibrium (p > 0.05 after Bonferroni correction), (5) keep variants passing GATK
VQSR (VQSRTranche of 90.0), (6) final hard filtering step with Quality by Depth
(QD) ≥ 2, FisherStrand (FS) ≤ 60, RMSMappingQuality (MQ) ≥ 40,
MappingQualityRankSumTest (MQRankSum) ≥−12.5, ReadPosRankSumTest
(ReadPosRankSum) ≥−8, StrandOddsRatio (SOR) ≤ 3 and ExcessHet ≤ 20.
Association study on rare and low-frequency variants in RetNet genes. An
association test was performed on rare and low-frequency non-synonymous var-
iants from a curated RetNet list (N= 228 genes, Suppl. Table 2) to test possible
association of variants in the 28 patients carrying rs118031911/T heterozygously
compared to 3554 controls from the ToMMo database31. More specifically, variants
were retained if they had a frequency comprised between 0.1 and 5% in controls,
with the exclusion of rs118031911/T itself, according to published methods60–62,
and in particular to the paper by Marouli and coworkers60. This resulted in the
selection of 178 variants in 84 different genes, which were used to test association
in rs118031911/T carriers vs. controls by Fisher’s exact test with an experiment-
wide Bonferroni-corrected threshold of 2.81 × 10−4, for α= 0.05 (0.05/178=
2.81 × 10−4). P-values and odds ratios were obtained by the fisher.test function
with default parameters in R (v3.5.1) and the Q–Q plot (Fig. 2) was obtained by
using the qqman package63.
Relatedness analyses. PLINK (v1.90b5)64 was used to compute PI_HAT values
between all pairs of the 28 rs118031911/T carriers using calls from whole exome
sequencing. This analysis showed no relatedness, with PI_HAT values between 0.00
and 0.07 (threshold for relatedness= 0.2)65, for all 378 possible pairwise combi-
nations (Supplementary Data 1).
SNP genotyping of the RP1 locus. To detect haplotypes in trans with respect to
rs118031911/T, we genotyped 23 SNPs encompassing the RP1 locus over ~260 kb,
by standard techniques.
Data availability
The data supporting the findings of this study, as a whole, contain information that could
compromise the privacy/consent of the participants, therefore we provide the genotypes
of the cases analyzed as a summary statistics file containing aggregated data
(Supplementary Data 2). Genotypes of control Japanese individuals from the ToMMo
Japanese Reference Panel Project (3.5KJPN release, v20181105open) can be accessed at
https://jmorp.megabank.tohoku.ac.jp/201905/downloads. Data from the BioBank Japan
Project and the Tohoku University School of Medicine and Yokohama City University
Graduate School of Medicine is available upon request to the corresponding author,
pending authorization of the Centers that generated them and in agreement with their
specific IRB approvals.
Code availability
Processing of raw sequence files, variant calling, variant annotation, as well as all the
other analyses described in this work were performed using available and open source
software, as detailed in the Methods section. No custom code was therefore used, aside
from simple scripts integrating commands for such programs.
Received: 21 September 2018 Accepted: 23 May 2019
References
1. den Hollander, A. I., Black, A., Bennett, J. & Cremers, F. P. Lighting a candle
in the dark: advances in genetics and gene therapy of recessive retinal
dystrophies. J. Clin. Invest. 120, 3042–3053 (2010).
2. Berger, W., Kloeckener-Gruissem, B. & Neidhardt, J. The molecular basis of
human retinal and vitreoretinal diseases. Prog. Retin. Eye Res. 29, 335–375
(2010).
3. Runhart, E. H. et al. The common ABCA4 Variant p.Asn1868Ile shows
nonpenetrance and variable expression of stargardt disease when present in
trans with severe variants. Invest. Ophthalmol. Vis. Sci. 59, 3220–3231 (2018).
4. Zernant, J. et al. Frequent hypomorphic alleles account for a significant
fraction of ABCA4 disease and distinguish it from age-related macular
degeneration. J. Med. Genet. 54, 404–412 (2017).
5. Jin, Z. B. et al. Identifying pathogenic genetic background of simplex or
multiplex retinitis pigmentosa patients: a large scale mutation screening study.
J. Med. Genet. 45, 465–472 (2008).
6. Khan, M. I. et al. The molecular basis of retinal dystrophies in pakistan. Genes
5, 176–195 (2014).
7. Yamaguchi-Kabata, Y. et al. Japanese population structure, based on SNP
genotypes from 7003 individuals compared to other ethnic groups: effects on
population-based association studies. Am. J. Hum. Genet. 83, 445–456 (2008).
8. Nishiguchi, K. M. & Rivolta, C. Genes associated with retinitis pigmentosa and
allied diseases are frequently mutated in the general population. PLoS One 7,
e41902 (2012).
9. Rivolta, C., Sharon, D., DeAngelis, M. M. & Dryja, T. P. Retinitis pigmentosa
and allied diseases: numerous diseases, genes, and inheritance patterns. Hum.
Mol. Genet. 11, 1219–1227 (2002).
10. den Hollander, A. I. & de Jong, E. K. Highly penetrant alleles in age-related
macular degeneration. Cold Spring Harb. Perspect. Med. 5, a017202 (2014).
11. Katsanis, N. et al. Triallelic inheritance in Bardet-Biedl syndrome, a
Mendelian recessive disorder. Science 293, 2256–2259 (2001).
12. Katsanis, N. The continuum of causality in human genetic disorders. Genome
Biol. 17, 233 (2016).
13. Badano, J. L. & Katsanis, N. Beyond Mendel: an evolving view of human
genetic disease transmission. Nat. Rev. Genet. 3, 779–789 (2002).
14. Pierce, E. A. et al. Mutations in a gene encoding a new oxygen-regulated
photoreceptor protein cause dominant retinitis pigmentosa. Nat. Genet. 22,
248–254 (1999).
15. Guillonneau, X. et al. A nonsense mutation in a novel gene is associated with
retinitis pigmentosa in a family linked to the RP1 locus. Hum. Mol. Genet. 8,
1541–1546 (1999).
16. Sullivan, L. S. et al. Mutations in a novel retina-specific gene cause autosomal
dominant retinitis pigmentosa. Nat. Genet. 22, 255–259 (1999).
17. Khaliq, S. et al. Novel association of RP1 gene mutations with autosomal
recessive retinitis pigmentosa. J. Med. Genet. 42, 436–438 (2005).
18. Avila-Fernandez, A. et al. Identification of an RP1 prevalent founder mutation
and related phenotype in Spanish patients with early-onset autosomal
recessive retinitis. Ophthalmology 119, 2616–2621 (2012).
19. El Shamieh, S. et al. Targeted next generation sequencing identifies novel
mutations in RP1 as a relatively common cause of autosomal recessive rod-
cone dystrophy. Biomed. Res. Int. 2015, 485624 (2015).
20. Baum, L. et al. RP1 in Chinese: Eight novel variants and evidence that
truncation of the extreme C-terminal does not cause retinitis pigmentosa.
Hum. Mutat. 17, 436 (2001).
21. Ziviello, C. et al. Molecular genetics of autosomal dominant retinitis
pigmentosa (ADRP): a comprehensive study of 43 Italian families. J. Med.
Genet. 42, e47 (2005).
22. Liu, Q. et al. Identification and subcellular localization of the RP1 protein in
human and mouse photoreceptors. Invest. Ophthalmol. Vis. Sci. 43, 22–32
(2002).
23. Liu, Q., Zuo, J. & Pierce, E. A. The retinitis pigmentosa 1 protein is a
photoreceptor microtubule-associated protein. J. Neurosci. 24, 6427–6436
(2004).
24. Iwanami, M., Oshikawa, M., Nishida, T., Nakadomari, S. & Kato, S. High
prevalence of mutations in the EYS gene in Japanese patients with autosomal
recessive retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 53, 1033–1040
(2012).
25. Suto, K. et al. Clinical phenotype in ten unrelated Japanese patients with
mutations in the EYS gene. Ophthalmic Genet. 35, 25–34 (2014).
26. Arai, Y. et al. Retinitis Pigmentosa with EYS mutations is the most prevalent
inherited retinal dystrophy in Japanese Populations. J. Ophthalmol. 2015,
819760 (2015).
27. Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans.
Nature 536, 285–291 (2016).
28. Hildebrandt, F., Benzing, T. & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364,
1533–1543 (2011).
29. Badano, J. L. et al. Dissection of epistasis in oligogenic Bardet-Biedl syndrome.
Nature 439, 326–330 (2006).
30. Lindstrand, A. et al. Copy-number variation contributes to the mutational
load of Bardet-Biedl syndrome. Am. J. Hum. Genet. 99, 318–336 (2016).
31. Nagasaki, M. et al. Rare variant discovery by deep whole-genome sequencing
of 1,070 Japanese individuals. Nat. Commun. 6, 8018 (2015).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10746-4
6 NATURE COMMUNICATIONS |         (2019) 10:2884 | https://doi.org/10.1038/s41467-019-10746-4 | www.nature.com/naturecommunications
32. Hanany, M. & Sharon, D. Allele frequency analysis of variants reported to
cause autosomal dominant inherited retinal diseases question the involvement
of 19% of genes and 10% of reported pathogenic variants. J. Med. Genet.
(2019).
33. Ji, W. et al. Rare independent mutations in renal salt handling genes
contribute to blood pressure variation. Nat. Genet. 40, 592–599 (2008).
34. Sykiotis, G. P. et al. Oligogenic basis of isolated gonadotropin-releasing
hormone deficiency. Proc. Natl Acad. Sci. USA 107, 15140–15144 (2010).
35. Kousi, M. et al. Evidence for secondary-variant genetic burden and non-
random distribution across biological modules in a recessive ciliopathy.
Preprint at https://www.biorxiv.org/content/10.1101/362707v1.full (2018).
36. Momozawa, Y. et al. Resequencing of positional candidates identifies low
frequency IL23R coding variants protecting against inflammatory bowel
disease. Nat. Genet. 43, 43–47 (2011).
37. Klassen, T. et al. Exome sequencing of ion channel genes reveals complex profiles
confounding personal risk assessment in epilepsy. Cell 145, 1036–1048 (2011).
38. Stessman, H. A. et al. Targeted sequencing identifies 91 neurodevelopmental-
disorder risk genes with autism and developmental-disability biases. Nat.
Genet. 49, 515–526 (2017).
39. Ebermann, I. et al. PDZD7 is a modifier of retinal disease and a contributor to
digenic Usher syndrome. J. Clin. Invest. 120, 1812–1823 (2010).
40. Kajiwara, K., Berson, E. L. & Dryja, T. P. Digenic retinitis pigmentosa due to
mutations at the unlinked peripherin/RDS and ROM1 loci. Science 264,
1604–1608 (1994).
41. Yoshimura, H. et al. Massively parallel DNA sequencing facilitates diagnosis
of patients with Usher syndrome type 1. PLoS ONE 9, e90688 (2014).
42. Beales, P. L. et al. Genetic interaction of BBS1 mutations with alleles at other
BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am. J. Hum.
Genet. 72, 1187–1199 (2003).
43. Zaghloul, N. A. & Katsanis, N. Functional modules, mutational load and
human genetic disease. Trends Genet. 26, 168–176 (2010).
44. Tory, K. et al. High NPHP1 and NPHP6 mutation rate in patients with
Joubert syndrome and nephronophthisis: potential epistatic effect of NPHP6
and AHI1 mutations in patients with NPHP1 mutations. J. Am. Soc. Nephrol.
18, 1566–1575 (2007).
45. Leitch, C. C. et al. Hypomorphic mutations in syndromic encephalocele genes
are associated with Bardet-Biedl syndrome. Nat. Genet. 40, 443–448 (2008).
46. Louie, C. M. et al. AHI1 is required for photoreceptor outer segment
development and is a modifier for retinal degeneration in nephronophthisis.
Nat. Genet. 42, 175–180 (2010).
47. Alfano, G. et al. EYS is a protein associated with the ciliary axoneme in rods
and cones. PLoS ONE 11, e0166397 (2016).
48. Lu, Z. et al. Ablation of EYS in zebrafish causes mislocalisation of outer
segment proteins, F-actin disruption and cone-rod dystrophy. Sci. Rep. 7,
46098 (2017).
49. Messchaert, M. et al. Eyes shut homolog is important for the maintenance of
photoreceptor morphology and visual function in zebrafish. PLoS ONE 13,
e0200789 (2018).
50. Goldberg, A. F., Moritz, O. L. & Williams, D. S. Molecular basis for
photoreceptor outer segment architecture. Prog. Retin. Eye Res. 55, 52–81
(2016).
51. Liu, Q., Lyubarsky, A., Skalet, J. H., Pugh, E. N. Jr. & Pierce, E. A. RP1 is
required for the correct stacking of outer segment discs. Invest. Ophthalmol.
Vis. Sci. 44, 4171–4183 (2003).
52. Genomics_England. The 100,000 Genomes Project Protocol v3. (2017).
53. Priest, J. R. et al. De novo and rare variants at multiple loci support the
oligogenic origins of atrioventricular septal heart defects. PLoS Genet. 12,
e1005963 (2016).
54. Katsanis, N. The oligogenic properties of Bardet-Biedl syndrome. Hum. Mol.
Genet. 13, R65–R71 (2004).
55. Drmanac, R. et al. Human genome sequencing using unchained base reads on
self-assembling DNA nanoarrays. Science 327, 78–81 (2010).
56. Nishiguchi, K. M. et al. Whole genome sequencing in patients with retinitis
pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new
disease gene. Proc. Natl Acad. Sci. USA 110, 16139–16144 (2013).
57. McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for
analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303
(2010).
58. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of
genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38,
e164 (2010).
59. Freeman, P. J., Hart, R. K., Gretton, L. J., Brookes, A. J. & Dalgleish, R.
VariantValidator: accurate validation, mapping, and formatting of sequence
variation descriptions. Hum. Mutat. 39, 61–68 (2018).
60. Marouli, E. et al. Rare and low-frequency coding variants alter human adult
height. Nature 542, 186–190 (2017).
61. Chang, J. et al. Exome-wide analyses identify low-frequency variant in
CYP26B1 and additional coding variants associated with esophageal
squamous cell carcinoma. Nat. Genet. 50, 338–343 (2018).
62. Do, R. et al. Exome sequencing identifies rare LDLR and APOA5
alleles conferring risk for myocardial infarction. Nature 518, 102–106
(2015).
63. Turner, S. D. qqman: an R package for visualizing GWAS results using Q-Q
and manhattan plots. Preprint at https://www.biorxiv.org/content/early/2014/
05/14/005165 (2014).
64. Purcell, S. et al. PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575
(2007).
65. Grove, J. et al. Identification of common genetic risk variants for autism
spectrum disorder. Nat. Genet. 51, 431–444 (2019).
Acknowledgements
This work was supported by the following agencies. The Swiss National Science Foun-
dation (grant #176097, to C.R.); the Rotterdamse Stichting Blindenbelangen, the Stichting
voor Ooglijders and the Nelly Reef fund (to M.I.K. and F.P.M.C.); the Japan Agency for
Medical Research and Development (grant #17ek0109213h0001) and the Japan Society
for the Promotion of Science (grant #16K11315, to K.M.N.); Research on Measures for
Intractable Diseases, Comprehensive Research on Disability Health and Welfare, the
Strategic Research Program for Brain Science, and the Initiative on Rare and Undiag-
nosed Diseases (all to N.Ma.); the Japanese Agency for Medical Research and Devel-
opment, Grants-in-Aid for Scientific Research (to N.Ma. and N.Mi.); the BioBank Japan
Project, by the Japanese Ministry of Education, Culture, Sport, Science and Technology
and the Japanese Agency for Medical Research and Development (to M.K.); the PhD
Fellowship in Life Sciences (Faculty of Biology and Medicine, University of Lausanne), to
M.Q. Most HRD patients were recruited from the Japanese Retinitis Pigmentosa Registry
Project (JRPRP). The authors would also like to warmly thank Dr. Matthew Robinson for
his expert advice on this work.
Author contributions
K.N., K.C., M.Q., and C.R. designed the research, wrote the manuscript, analyzed all the
data, and interpreted the results. H.K.K. performed the analyses of the WGS sample and
segregation analyses of the families. N.Mi. screened control individuals for the RP1
mutations. P.F., A.U.R., and K.N. performed Sanger sequencing analyses. A.P. con-
tributed to the statistical analyses, while M.A., F.M., and K.M.N. analyzed the data.
Under the coordination of K.M.N. and T.N., Y.I., S.U., N.F., A.M., Y.W., H.T., K.-H.S., T.
I., K.M.N., and T.N. examined the patients and collected biological samples for genetic
analysis. Y.K., C.T., N.Ma., and M.K. provided access to databases of control individuals.
M.I.K. and F.P.M.C. provided part of the sequencing data. Z.K. supervised the statistical
analysis and wrote part of the manuscript. C.R. was the principal investigator of this
study. All authors read and commented on the article.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
019-10746-4.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Peer review information: Nature Communications thanks the anonymous reviewers for
their contribution to the peer review of this work.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10746-4 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2884 | https://doi.org/10.1038/s41467-019-10746-4 |www.nature.com/naturecommunications 7
